LabCorp
Answers that advance medicine
Burlington, North Carolina, U.S.
Provides an API platform connecting wearables, medical devices, and lab services for unified health data access.
How We Help
Core Technology
API platform
Key Differentiators
Comprehensive laboratory services for diagnostics and drug development; API platform for unified health data access; Vast menu of routine and specialty tests; Leverages advanced technology including AI to enhance healthcare decisions; Significant support for new drug approvals by the FDA; Pioneering in specific diagnostic tests (e.g., Alzheimer's blood test, liquid biopsy for cancer)
Clinical Focus
Drug Development
Target Customers
physicians, biopharma companies, consumers, hospitals/health systems
Product Stage
Mature
Company Info
- Business Model
- Hybrid
- Founded
- 1969
- Total Funding
- 27,000,000,000
- Website
- www.labcorp.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA-cleared Alzheimer's blood test (2024). Expanded MRD testing for stage I-III breast cancer, stage I-IIIA non-small cell lung cancer, stage III colon cancer. Supported 86% of 2024 FDA-approved oncology drugs. Central lab generates more clinical trial data than all other central labs combined.
MedStartr Index Score
?What do you think of LabCorp?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.